GTG genetic technologies limited

up 85% today , what gives?!!, page-20

  1. 181 Posts.
    If anyone buys this stock based on licensing revenue they will sadly disappointed as you simply cannot sustain a business on revenue from expired or near to expired patents. How can a business that spends more on staff costs alone that it earns from non licensing business (and has done for 10 years) ever succeed. While they appear to finally have got the licensing strategy right (exit stage left Merv), you have to look at the core business which will never work as it is a very very competive market. You can be sure that once any one of their product lines starts to generate any consumer interest, companies far larger than GTG will start to compete and blow them out of the water. The best hope for anyone trading in this stock is to hope the liquidity stays high which given how much the top 20 own is a real risk for traders who if you get caught will get burned big time.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.